- Home
- ENSC vs VEEE Comparison
ENSC vs VEEE Comparison
Compare ENSC & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- VEEE
- Stock Information
- Founded
- ENSC 2003
- VEEE 1994
- Country
- ENSC United States
- VEEE United States
- Employees
- ENSC N/A
- VEEE N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- VEEE Marine Transportation
- Sector
- ENSC Health Care
- VEEE Industrials
- Exchange
- ENSC Nasdaq
- VEEE Nasdaq
- Market Cap
- ENSC 5.5M
- VEEE 6.4M
- IPO Year
- ENSC N/A
- VEEE 2021
- Fundamental
- Price
- ENSC $2.64
- VEEE $0.35
- Analyst Decision
- ENSC
- VEEE
- Analyst Count
- ENSC 0
- VEEE 0
- Target Price
- ENSC N/A
- VEEE N/A
- AVG Volume (30 Days)
- ENSC 24.9K
- VEEE 53.2K
- Earning Date
- ENSC 05-12-2025
- VEEE 03-20-2025
- Dividend Yield
- ENSC N/A
- VEEE N/A
- EPS Growth
- ENSC N/A
- VEEE N/A
- EPS
- ENSC N/A
- VEEE N/A
- Revenue
- ENSC $5,210,031.00
- VEEE $14,388,517.00
- Revenue This Year
- ENSC N/A
- VEEE N/A
- Revenue Next Year
- ENSC N/A
- VEEE N/A
- P/E Ratio
- ENSC N/A
- VEEE N/A
- Revenue Growth
- ENSC 133.58
- VEEE N/A
- 52 Week Low
- ENSC $2.12
- VEEE $0.31
- 52 Week High
- ENSC $14.67
- VEEE $0.99
- Technical
- Relative Strength Index (RSI)
- ENSC 23.45
- VEEE 42.80
- Support Level
- ENSC $3.30
- VEEE $0.32
- Resistance Level
- ENSC $3.58
- VEEE $0.42
- Average True Range (ATR)
- ENSC 0.32
- VEEE 0.03
- MACD
- ENSC -0.05
- VEEE -0.00
- Stochastic Oscillator
- ENSC 22.21
- VEEE 30.00
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.